Comprehensive and Progressive Agreement for Trans-Pacific Partnership
3-Aug-2013
A public consultation session here intended to gather feedback on the proposed Trans-Pacific Partnership Agreement (TPPA) garnered mostly hostile response from the participants.
31-Jul-2013
Malaysia's Parti Keadilan Rakyat VP Nurul Izzah Anwar has accused the Ministry of International Trade and Industry of bowing down to pressure when it agreed to clauses on investor-state dispute settlement in negotiations for the Trans Pacific Partnership (TPP) agreement.
29-Jul-2013
Our Fair Deal
The Fair Deal Coalition has launched a new initiative that will give Internet users a platform to discuss what copyright should look like under the TPP.
23-Jul-2013
U.S. auto workers have started delivering to Washington petitions demanding trade concessions from Japan on the same day Japan formally announced it had joined in U.S.-led effort to create the multi-lateral Trans-Pacific Partnership (TPP), the largest free-trade agreement in history that would cover 40 percent of the global economy.
22-Jul-2013
The Asia Pacific region is leading the world in mobile computing, enabling the small and medium enterprises (SMEs) to leapfrog into large business opportunities.
20-Jul-2013
Malaysia should exclude medical and tobacco businesses in the ongoing free trade talks under the Trans-Pacific Partnership Agreement (TPPA).
20-Jul-2013
Malaysian police on Saturday detained 14 people protesting against ongoing negotiations for a huge trans-Pacific free trade deal.
19-Jul-2013
GLW
The Socialist Party of Malaysia has no illusion about the true colours and intent of the TPPA/FTA as an agenda of US mega corporations.
17-Jul-2013
Chambers of commerce in the country have lent their support to the Trans-Pacific Partnership (TPP) trade negotiations, saying it promotes a secure and mutually beneficial trade environment and brings greater opportunities for participating countries.
17-Jul-2013
Canada is pushing back against a campaign by activists trying to block what they say are onerous intellectual property rules that would raise the price of pharmaceuticals in poor countries.